A subanalysis from the Diabetes Remission Clinical Trial (DiRECT) points to changes in hepatic metabolism as a cause for patients with type 2 diabetes entering remission after dramatic weigh... Read more

Jeffrey Krischer, PhD, will moderate a Saturday afternoon symposium reviewing lessons learned from the Environmental Determinants of Diabetes in the Young (TEDDY) Study, which will begin at... Read more

It’s been a decade since U.S. and European regulatory agencies began requiring cardiovascular outcomes assessment as an extension of all clinical trials involving diabetes medications. Some... Read more

With ongoing research and breakthrough discoveries developing in the diabetes space, health professionals continue to embrace emerging technologies at American Diabetes Association camps, wh... Read more

During a Saturday afternoon symposium jointly sponsored by the ADA and the International Society for Pediatric and Adolescent Diabetes (ISPAD), four international experts will take a retrosp... Read more

Islet transplantation has long been seen as an effective alternative to regular insulin injections in type 1 diabetes. Some models have shown limited success in humans, but grafts eventually... Read more

Newer “smart” apps and advanced Bluetooth-enabled diabetes devices are designed to appeal to a broad audience by providing personalized functions and disease management support. Three techno... Read more

Current literature suggests that dual antiplatelet therapy is indicated for at least a year after an acute coronary syndrome event in all patients, but it appears to be particularly importan... Read more

The mechanisms that cause beta cells to decrease or cease insulin secretion in response to glucose are not clear. It’s not even clear what a physiologically normal complement of beta cells m... Read more

Words matter. Those two words were woven through a Sunday morning address by Alvin C. Powers, MD, ADA President, Medicine & Science. Today’s researchers and clinicians work in a 140-char... Read more